Published in J Clin Oncol on February 01, 1986
Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer. Proc Natl Acad Sci U S A (2015) 1.26
Estimation of tumor heterogeneity using CGH array data. BMC Bioinformatics (2009) 1.14
Evolutionary dynamics of intratumor heterogeneity. PLoS One (2011) 1.14
Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies. Br J Cancer (2013) 1.07
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget (2014) 1.06
Highly-efficient single-cell capture in microfluidic array chips using differential hydrodynamic guiding structures. Appl Phys Lett (2011) 1.00
Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel. Br J Cancer (1996) 1.00
Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma. Br J Cancer (2004) 1.00
Doxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia. J Control Release (2012) 0.98
Tumor heterogeneity in neoplasms of breast, colon, and skin. BMC Res Notes (2010) 0.97
Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake. Nano Lett (2012) 0.97
Mechanisms of tumor resistance to EGFR-targeted therapies. Expert Opin Ther Targets (2009) 0.96
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset. Proc Natl Acad Sci U S A (2014) 0.95
Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. Ann Surg (1998) 0.93
Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.91
Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types. Mol Pharm (2014) 0.90
Cancer immunoediting of the NK group 2D ligand H60a. J Immunol (2011) 0.89
Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges. J Gastroenterol (2011) 0.86
Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake. Nano Lett (2014) 0.84
Dynamics of growth factor production in monolayers of cancer cells and evolution of resistance to anticancer therapies. Evol Appl (2013) 0.83
Transcriptomic Heterogeneity in Cancer as a Consequence of Dysregulation of the Gene-Gene Interaction Network. Bull Math Biol (2015) 0.81
Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets. Oncotarget (2016) 0.80
Fluorescence Lifetime Imaging of Apoptosis. Tomography (2015) 0.79
Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells. Br J Cancer (1997) 0.79
Traceable clonal culture and chemodrug assay of heterogeneous prostate carcinoma PC3 cells in microfluidic single cell array chips. Biomicrofluidics (2014) 0.78
Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients. Front Oncol (2016) 0.78
Pathology to enhance precision medicine in oncology: lessons from landscape ecology. Adv Anat Pathol (2015) 0.77
Quantifying and Reducing Uncertainties in Cancer Therapy. Proc SPIE Int Soc Opt Eng (2015) 0.76
Chemotherapy promotes tumour cell hybridization in vivo. Tumour Biol (2015) 0.76
High-Throughput Single-Cell Derived Sphere Formation for Cancer Stem-Like Cell Identification and Analysis. Sci Rep (2016) 0.76
Competitive exclusion of clonal subpopulations in heterogeneous tumours after stromal injury. Br J Cancer (1989) 0.75
Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature. Br J Cancer (2017) 0.75
Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors. Phys Med Biol (2016) 0.75
Clonal cooperativity in heterogenous cancers. Semin Cell Dev Biol (2016) 0.75
Microfluidics 3D gel-island chip for single cell isolation and lineage-dependent drug responses study. Lab Chip (2016) 0.75
Eradication of therapy-resistant cancer cells in gastrointestinal organs. Mol Clin Oncol (2012) 0.75
Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells. Lab Chip (2016) 0.75
Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res (1978) 2.86
N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res (1979) 2.05
Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med (1981) 1.56
Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res (1978) 1.48
The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine. Cancer Res (1972) 1.19
Clinical and pharmacological implications of cancer cell differentiation and heterogeneity. Biochem Pharmacol (1979) 1.15
Polar solvents: a novel class of antineoplastic agents. J Clin Oncol (1984) 1.15
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers. Cancer Chemother Pharmacol (1994) 1.08
Intraneoplastic diversity. Biochim Biophys Acta (1982) 1.06
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. Cancer Res (1997) 1.02
Human tumor cell heterogeneity and metastasis. J Clin Oncol (1983) 1.01
Cellular radiosensitivity of a rat brain tumor. Cancer (1975) 0.98
Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J Med Chem (1990) 0.97
[Mouse teratocarcinoma: isolation and characterization of two muscle cell lines (author's transl)]. Ann Microbiol (Paris) (1976) 0.97
Growth properties of artificial heterogeneous human colon tumors. Cancer Res (1987) 0.96
Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst (1993) 0.95
Adaptation of Sinclair swine melanoma cells to long-term growth in vitro. Cancer Res (1979) 0.94
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res (1990) 0.94
N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells. Cancer Res (1977) 0.93
Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors. Cancer Res (1985) 0.93
Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB). Radiat Res (1985) 0.92
Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res (1988) 0.91
Chemotherapy of cell-line-derived human colon carcinomas in mice immunosuppressed with antithymocyte serum. Cancer (1977) 0.89
Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells. Histochem J (1984) 0.89
Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice. Cancer Res (1982) 0.89
Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase. Biochem Pharmacol (1990) 0.89
Characterization of a defect in the pathway for converting 5'-deoxy-5'-methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma. J Biol Chem (1984) 0.88
Polar solvent-induced changes in membrane lipid lateral diffusion in human colon cancer cells. Cancer Res (1985) 0.86
Maturation-induction of tumor cells using a human colon carcinoma model. Cancer (1980) 0.86
Alteration of the survival response of two human colon carcinoma subpopulations to x-irradiation by N,N-dimethylformamide. Cancer Res (1982) 0.86
Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF). Int J Radiat Oncol Biol Phys (1985) 0.86
Characterization of two metastatic subpopulations originating from a single human colon carcinoma. Cancer Res (1983) 0.85
Positive feedback and angiogenesis in tumor growth control. Bull Math Biol (1997) 0.85
Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents. Int J Radiat Oncol Biol Phys (1986) 0.85
Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice. Cancer Res (1984) 0.85
Differential RBE values obtained for mammary adenocarcinoma tumor cell subpopulations after 14.8-MeV neutron irradiation. Radiat Res (1981) 0.84
Disaggregation studies of xenograft solid tumors grown from pure or admixed clonal subpopulations from a heterogeneous human colon adenocarcinoma. Invasion Metastasis (1985) 0.84
Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control. J Theor Biol (1994) 0.84
Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J Neurosci Res (1990) 0.83
Radiation myelopathy in the rat: an interpretation of dose effect relationships. Int J Radiat Oncol Biol Phys (1981) 0.83
Tumor micro-ecology and competitive interactions. J Theor Biol (1987) 0.83
Host response in tumor growth and progression. Invasion Metastasis (1996) 0.82
Erythrocyte glutathione and tumour response to chemotherapy. Lancet (1992) 0.82
Inhibition of the growth of human colon cancer xenografts by polar solvents. Cancer Res (1982) 0.82
Early effects of single doses of 375 MeV/nucleon 20Neon ions on the skin of mice and hamsters. Radiat Res (1976) 0.81
Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. Cancer Res (1994) 0.81
Morphologic and morphometric analysis of the early effects of x-ray and heavy-ion irradiation of hamster lung. Am J Pathol (1976) 0.81
Letter: Tolerance of the spinal cord of rats to irradiation with neon ions. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 0.81
N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells. Cancer Res (1981) 0.80
2'-Deoxycoformycin-induced hemolysis in the mouse. J Natl Cancer Inst (1982) 0.80
Growth in solid heterogeneous human colon adenocarcinomas: comparison of simple logistical models. Cell Tissue Kinet (1987) 0.80
Antitumor activity and toxicity of novel nitroheterocyclic phosphoramidates. J Med Chem (2001) 0.80
Comparison of basic fibroblast growth factor levels in clone A human colon cancer cells in vitro with levels in xenografted tumours. Br J Cancer (1995) 0.80
Conversion of 5'-deoxy-5'-methylthioadenosine and 5'-deoxy-5'-methylthioinosine to methionine in cultured human leukemic cells. Cancer Res (1983) 0.79
Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumors. Biochem Pharmacol (1981) 0.79
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. Int J Oncol (2001) 0.79
Growth factors and growth control of heterogeneous cell populations. Bull Math Biol (1993) 0.79
Comparison of skin responses of mice after single or fractionated exposure to cyclotron-accelerated helium ions and 230 kv x-irradiation. Radiat Res (1975) 0.79
N,N-dimethylformamide-induced modulation of organ- and tumor-associated markers in cultured human colon carcinoma cells. J Natl Cancer Inst (1980) 0.79
Letter: Response of a rat brain tumour to irradiation with accelerated neon ions. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 0.79
Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice. J Natl Cancer Inst (1983) 0.79
Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. Cancer Res (1982) 0.79
Distribution of the novel anticancer drug candidate Brequinar sodium (DuP 785, NSC 368390) into normal and tumor tissues of nude mice bearing human colon carcinoma xenografts. Cancer Chemother Pharmacol (1988) 0.78
Stochastic models for subpopulation emergence in heterogeneous tumors. Bull Math Biol (1989) 0.78
Spontaneous remission of metastatic lung cancer following myxedema coma--an apoptosis-related phenomenon? J Natl Cancer Inst (1993) 0.78
Effects of nucleoside analogs and sodium butyrate on recovery from potentially lethal X ray damage in human colon tumor cells. Int J Radiat Oncol Biol Phys (1987) 0.78
Comparison of the effects of epidermal chalone in young and aging mice. Cell Tissue Kinet (1978) 0.78
Effect of dose rate on production of early and late radiation damage in mouse skin. Int J Radiat Oncol Biol Phys (1977) 0.78
Induction by butyrate of differentiated properties in cloned murine rhabdomyosarcoma cells. Differentiation (1981) 0.78
In vitro sublethal damage repair in tumour subpopulations from a heterogeneous human colon tumour. Br J Cancer Suppl (1984) 0.78
Thermal survival characteristics of cell subpopulations isolated from a heterogeneous human colon tumor. Cancer Res (1983) 0.78
Cell cycle responses of heterogeneous human colon adenocarcinoma subpopulations to X-irradiation. Cell Tissue Kinet (1987) 0.77
Response of 9L tumor cells to hyperthermia and X irradiation. Radiat Res (1979) 0.77
Enteraction of hyperthermia with radiations of different linerar energy transfer. Int J Radiat Biol Relat Stud Phys Chem Med (1977) 0.77
Intrinsic and extrinsic heterogeneity in the responses of parent and clonal human colon carcinoma xenografts to photon irradiation. Cancer Res (1984) 0.77
"COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude mice. Cancer Res (1983) 0.76
5'-deoxy-5'-methylthioadenosine phosphorylase--II. Role of the enzyme in the metabolism and antineoplastic action of adenine-substituted analogs of 5'-deoxy-5'-methylthioadenosine. Biochem Pharmacol (1983) 0.76
Response of rat spinal cord to single and fractionated doses of accelerated heavy ions. Radiat Res (1982) 0.76
Hyperthermic potentiation: biological aspects and applications to radiation therapy. Cancer (1977) 0.76
Tolerance of the spinal cord of rats to irradiation with cyclotron-accelerated heliumions. Cancer (1975) 0.76
A function which describes quantitative adsorptions of antibodies by cell-surface antigens. Immunochemistry (1976) 0.76
Survival of mouse-skin epithelial cells after heavy-particle irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 0.76
Effects of topically-applied olive oil on the response of hamster skin to single or multiple doses of 230kV X-rays. Int J Radiat Biol Relat Stud Phys Chem Med (1977) 0.76
A technique to analyse the emerging zonality of heterogeneous solid tumours. Cell Tissue Kinet (1987) 0.76
Effects of the differentiating agents sodium butyrate and N-methylformamide on the oxygen enhancement ratio of human colon tumor cells. Radiat Res (1988) 0.76
Suramin and tumor cell radiosensitivity. Eur J Cancer (1991) 0.75
Use of micronuclei formation following graded doses of radiation as a marker for the intrinsic sensitivity of tumors in vivo. Radiother Oncol (1993) 0.75
Combined modality therapy in high dose radioneurosurgery. Radiother Oncol (1993) 0.75
Comparison of heavy particle with X-irradiation on the hamster lung. Am J Pathol (1979) 0.75
Metastasis of a human pancreatic adenocarcinoma (RWP-1) in nude mice. Br J Cancer (1982) 0.75
Correspondence Re: D. G. Brachman et al., Mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res., 53: 3667-3669, 1993. Cancer Res (1994) 0.75
In response to Chiang et al. Int J Radiat Oncol Biol Phys (1995) 0.75